BACKGROUND:Rates of mental illness in children are increasing throughout the world. Observational studies of depression, anxiety, and attention-deficit hyperactivity disorder suggest that zinc is an alternative treatment. OBJECTIVE: We examined the effect of zinc supplementation on the mental health of school-age children in Guatemala. DESIGN: From January to October 2006, we conducted a 6-mo randomized, double-blind, controlled trial comparing zinc supplementation (10 mg ZnO/d for 5 d/wk) with a placebo (10 mg glucose) in 674 Guatemalan children in grades 1-4. Outcome measures included internalizing (ie, depression and anxiety) and externalizing (ie, hyperactivity and conduct disorder) problem behaviors, positive behaviors (ie, socialization and leadership), and serum zinc concentrations. RESULTS:Zinc and placebo groups did not differ significantly in any behavioral measures at baseline or at follow-up. At baseline, 21.4% of children had serum zinc concentrations <65 μg/dL. At follow-up, both groups improved significantly, and zinc concentrations were higher in the zinc group. Increases in serum zinc concentrations were inversely associated with decreases in depressive symptoms (estimate: -0.01 points per μg Zn/dL; P = 0.01), anxiety (estimate: -0.012 points per μg Zn/dL; P = 0.02), internalizing symptoms (estimate: -0.021 points per μg Zn/dL; P = 0.02), and social skills (estimate: -0.019 points per μg Zn/dL; P = 0.01) in adjusted models that were controlled for child age, sex, socioeconomic status, household, and treatment group. CONCLUSIONS: Six months of zinc supplementation did not induce differences in mental health outcomes between zinc and placebo groups. However, increases in serum zinc concentrations were associated with decreases in internalizing symptoms (ie, depression and anxiety) in a community-based sample of children at risk of zinc deficiency. This trial was registered at clinicaltrials.gov as NCT00283660.
RCT Entities:
BACKGROUND: Rates of mental illness in children are increasing throughout the world. Observational studies of depression, anxiety, and attention-deficit hyperactivity disorder suggest that zinc is an alternative treatment. OBJECTIVE: We examined the effect of zinc supplementation on the mental health of school-age children in Guatemala. DESIGN: From January to October 2006, we conducted a 6-mo randomized, double-blind, controlled trial comparing zinc supplementation (10 mg ZnO/d for 5 d/wk) with a placebo (10 mg glucose) in 674 Guatemalan children in grades 1-4. Outcome measures included internalizing (ie, depression and anxiety) and externalizing (ie, hyperactivity and conduct disorder) problem behaviors, positive behaviors (ie, socialization and leadership), and serum zinc concentrations. RESULTS: Zinc and placebo groups did not differ significantly in any behavioral measures at baseline or at follow-up. At baseline, 21.4% of children had serum zinc concentrations <65 μg/dL. At follow-up, both groups improved significantly, and zinc concentrations were higher in the zinc group. Increases in serum zinc concentrations were inversely associated with decreases in depressive symptoms (estimate: -0.01 points per μg Zn/dL; P = 0.01), anxiety (estimate: -0.012 points per μg Zn/dL; P = 0.02), internalizing symptoms (estimate: -0.021 points per μg Zn/dL; P = 0.02), and social skills (estimate: -0.019 points per μg Zn/dL; P = 0.01) in adjusted models that were controlled for child age, sex, socioeconomic status, household, and treatment group. CONCLUSIONS: Six months of zinc supplementation did not induce differences in mental health outcomes between zinc and placebo groups. However, increases in serum zinc concentrations were associated with decreases in internalizing symptoms (ie, depression and anxiety) in a community-based sample of children at risk of zinc deficiency. This trial was registered at clinicaltrials.gov as NCT00283660.
Authors: M Leyton; S N Young; R O Pihl; S Etezadi; C Lauze; P Blier; G B Baker; C Benkelfat Journal: Neuropsychopharmacology Date: 2000-01 Impact factor: 7.853
Authors: D A Pineda; R W Kamphaus; O Mora; I C Puerta; L G Palacio; I Jiménez; S Mejía; M García; J C Arango; M E Jiménez; F Lopera Journal: Rev Neurol Date: 1999 May 16-31 Impact factor: 0.870
Authors: H H Sandstead; J G Penland; N W Alcock; H H Dayal; X C Chen; J S Li; F Zhao; J J Yang Journal: Am J Clin Nutr Date: 1998-08 Impact factor: 7.045
Authors: Joseph Murray; Yulia Shenderovich; Frances Gardner; Christopher Mikton; James H Derzon; Jianghong Liu; Manuel Eisner Journal: Crime Justice Date: 2018-03-26
Authors: L Eugene Arnold; Robert A Disilvestro; Dawn Bozzolo; Hernan Bozzolo; Lindsay Crowl; Soledad Fernandez; Yaser Ramadan; Susan Thompson; Xiaokui Mo; Mahmoud Abdel-Rasoul; Elizabeth Joseph Journal: J Child Adolesc Psychopharmacol Date: 2011-02 Impact factor: 2.576
Authors: Vinh Q Bui; Aryeh D Stein; Ann M DiGirolamo; Usha Ramakrishnan; Rafael C Flores-Ayala; Manuel Ramirez-Zea; Frederick K Grant; Salvador Villalpando; Reynaldo Martorell Journal: Biol Trace Elem Res Date: 2012-02-22 Impact factor: 3.738
Authors: Alison J McAfee; Maria S Mulhern; Emeir M McSorley; Julie M W Wallace; Maxine P Bonham; Jude Faure; Sarah Romain; Christina Esther; Conrad F Shamlaye; Gene E Watson; Gary J Myers; Thomas W Clarkson; Philip W Davidson; J J Strain Journal: Public Health Nutr Date: 2012-02-10 Impact factor: 4.022
Authors: Vinh Q Bui; Jessica Marcinkevage; Usha Ramakrishnan; Rafael C Flores-Ayala; Manuel Ramirez-Zea; Salvador Villalpando; Reynaldo Martorell; Ann M DiGirolamo; Aryeh D Stein Journal: Food Nutr Bull Date: 2013-06 Impact factor: 2.069